Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ponatinib D8 is a deuterium labeled Ponatinib. Ponatinib is an orally active inhibitor of multi-targeted kinase(Abl, PDGFRα, VEGFR2, FGFR1, and Src with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM, respectively).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $278 | 35 days | |
5 mg | $678 | 7-10 days |
Description | Ponatinib D8 is a deuterium labeled Ponatinib. Ponatinib is an orally active inhibitor of multi-targeted kinase(Abl, PDGFRα, VEGFR2, FGFR1, and Src with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM, respectively). |
Targets&IC50 | PDGFRα:1.1 nM, c-Kit:12.5 nM, FGFR1:2.2 nM, VEGFR2:1.5 nM |
Alias | AP24534 D8 |
Molecular Weight | 540.61 |
Formula | C29H27F3N6O |
Cas No. | 1562993-37-6 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.